SNAP-25-related octapeptide (cosmetic research)
SNAP-8
Competitive peptide related to the SNAP-25 SNARE motif, studied for attenuating SNARE-mediated catecholamine release in wrinkle-modulation cosmetics.
Primary Mechanism of Action
Clinical / Scientific
SNAP-8 (acetyl octapeptide-3) was designed as a SNAP-25 fragment analogue to interfere with SNARE complex assembly and reduce vesicle release in neuromuscular models used by cosmetic science. It is not botulinum toxin and not a licensed neurologic drug.
Pathway Targets
SNARE / SNAP-25
Scientific explanation
Competitive interference with vesicle fusion in cosmetic models.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Receptor to physiology
Target to downstream effect: SNARE / SNAP-25
Mechanistically Relevant Repurposed & Adjunctive Applications
Research peptide context
PreclinicalMechanistic rationale
Catalogued as a research peptide. Mechanistic statements below describe known or pathway biology and do not establish a licensed therapeutic indication.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| SNAP-25 | Competitive peptide | Cosmetic neuromuscular models | Preclinical / cosmetic |
In Plain Language
SNAP-8 is a cosmetic peptide inspired by a nerve-terminal docking protein. It is a far milder, different idea from botulinum toxin injections.
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.